We are the first to use an off-label drug, amiodarone, to induce autophagy in the lung-to-lung metastasis mice model and to demonstrate that amiodarone-induced secretory autophagy could increase TIMP1 secretion and suppress the motility of lung cancer cells both in vitro and in vivo. Here, TIMP1 is linked to lung carcinoma.